Medical Ikkou Group Co (TSE:3353) ROCE % : 9.98% (As of Nov. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Medical Ikkou Group Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medical Ikkou Group Co's annualized ROCE % for the quarter that ended in Nov. 2023 was 9.98%.

Medical Ikkou Group Co ROCE % Historical Data

The historical data trend for Medical Ikkou Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medical Ikkou Group Co ROCE % Chart

Medical Ikkou Group Co Annual Data

Trend

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

ROCE %

Get a 7-Day Free Trial

7.06

7.37

7.94

7.65

6.70

Medical Ikkou Group Co Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
ROCE %	Get a 7-Day Free Trial															7.75	6.59	7.71	8.12	9.98

Medical Ikkou Group Co ROCE % Calculation

Medical Ikkou Group Co's annualized ROCE % for the fiscal year that ended in Feb. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Feb. 2023 )		(A: Feb. 2022 )		(A: Feb. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Feb. 2023 )		(A: Feb. 2022 )		(A: Feb. 2023 )
	=	1364.568	/	( ( (29094.256 - 8416.097)	+	(27505.776 - 7454.768) )	/ 2 )
	=	1364.568	/	( (20678.159	+	20051.008)	/ 2 )
	=	1364.568	/	20364.5835
	=	6.70 %

Medical Ikkou Group Co's ROCE % of for the quarter that ended in Nov. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Nov. 2023 )		(Q: Aug. 2023 )		(Q: Nov. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Nov. 2023 )		(Q: Aug. 2023 )		(Q: Nov. 2023 )
	=	2052.776	/	( ( (28480.67 - 7894.294)	+	(32765.53 - 12197.936) )	/ 2 )
	=	2052.776	/	( ( 20586.376	+	20567.594 )	/ 2 )
	=	2052.776	/	20576.985
	=	9.98 %

(1) Note: The EBIT data used here is four times the quarterly (Nov. 2023) EBIT data.

Medical Ikkou Group Co (TSE:3353) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medical Ikkou Group Co ROCE % Related Terms

Thank you for viewing the detailed overview of Medical Ikkou Group Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medical Ikkou Group Co (TSE:3353) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Medical Ikkou Group Co Ltd (TSE:3353) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

501 62 Fujikata, Mie Prefecture, Tsu, JPN, 514-0815

Website

http://www.m-ikkou.co.jp

Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.

Medical Ikkou Group Co (TSE:3353) Headlines

No Headlines